sig abbreviations and routes of administration Flashcards
a
Before
aa
Of each
aaa
apply to effected area
a.c.
before meals
a.d.
right ear
a.m.
morning
amp
ampule
aq.
water
aq. dist.
Distilled water
a.s.
left ear
a.u.
Each ear
b.i.d.
twice a day
b.i.w.
twice a week
c
with
cc
cubic centimeter
cap
capsule
cd
cycle day
DAW
dispense as written
disc or D.C.
discontinue
DS
double strength
eq
equivalent
elix.
elixir
g or Gm
gram
gr
grain
gtt
drops
h or hr
hour
h.s.
at bedtime
IM
intramuscular
inj.
injection
IU
international units
IV
intravenous
Kg
kilogram
mcg
microgram
mg
milligram
ml
milliliter
neb
nebulizer
non rep. or NR
no refills
o.d.
right eye
o.l.
left eye
o.s.
left eye
o.u.
both eyes
oz
ounce
p.c.
after meals
post
after
pr
rectally
p.r.n.
as required or as needed
pv
vaginally
q
every
qd
every day
qh
every hour
qid
four times per day
qod
every other day
qs
a sufficient quantity
qs ad
a sufficient quantity to make
r
rectal
s
sans (without)
ss
one half
sig
directions
SL
sublingual
stat
immediately
subq or SC
subcutaneous
supp.
suppository
susp.
suspension
tab
tablet
tid
three times a day
tiw
three times a week
tx
treatment
U
units
u.d. or utd or ut dict
as directed
wc
with meals
Category A
Adequate studies showed no risk to fetus
Category B
Animal reproduction studies failed to show risk to fetus
Category C
Animal reproduction studies showed adverse effects on the fetus
Category D
Positive evidence of human fetal risk
Category X
Studies have demonstrated fetal abnormalities. The risks to the fetus clearly outweigh the benefits to the mother.
Schedule I
No accepted medical use, lack of safety and a high potential for abuse
Schedule II
High potential for abuse, may lead to dependence
Schedule III
Potential for abuse and a moderate chance of dependency
Schedule IV
Low potential for abuse
Schedule V
Lowest potential for abuse
po
Oral
CR, ER, SR
Continuous Release, Extended Release, Slow Release